Holen Sie sich die Stockscreener-App
0.9654
8.84%
0.0784
Handel nachbörslich:
.93
-0.0354
-3.67%
Schlusskurs vom Vortag:
$0.887
Offen:
$0.88
24-Stunden-Volumen:
193.39K
Relative Volume:
1.21
Marktkapitalisierung:
$18.88M
Einnahmen:
$411.00K
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-2.1941
EPS:
-0.44
Netto-Cashflow:
$-4.88M
1W Leistung:
+8.47%
1M Leistung:
+10.33%
6M Leistung:
-20.21%
1J Leistung:
-71.94%
1-Tages-Spanne:
$0.8706
$0.9656
1-Wochen-Bereich:
$0.8571
$0.9656
52-Wochen-Spanne:
$0.7749
$3.72
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Firmenname
Lexaria Bioscience Corp
Sektor
Branche
Telefon
250-765-6424
Adresse
100 - 740 MCCURDY ROAD, KELOWNA
Vergleichen Sie LEXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.9654 | 17.33M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
Can Lexaria Bioscience Corp. Equity Warrant ride the EV waveJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - khodrobank.com
Using data filters to optimize entry into Lexaria Bioscience Corp. Equity WarrantMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Will Lexaria Bioscience Corp. Equity Warrant stock go up soonWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser
How sentiment analysis helps forecast Lexaria Bioscience Corp. Equity WarrantQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Can Lexaria Bioscience Corp. be the next market leader2025 Institutional Moves & Community Consensus Stock Picks - khodrobank.com
Is Lexaria Bioscience Corp. Equity Warrant showing signs of accumulationGold Moves & Risk Managed Investment Signals - Newser
Is Lexaria Bioscience Corp. Equity Warrant stock undervalued right now2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com
Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Portfolio Value Summary & Weekly High Momentum Picks - Newser
Is Lexaria Bioscience Corp. a defensive stock2025 Pullback Review & Weekly Return Optimization Alerts - khodrobank.com
Will Lexaria Bioscience Corp. Equity Warrant see short term momentum2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Lexaria Bioscience Corp.’s volatility index tracking explainedTrade Risk Report & Risk Controlled Daily Plans - Newser
What machine learning models say about Lexaria Bioscience Corp. Equity WarrantJuly 2025 Update & Community Supported Trade Ideas - Newser
Full technical analysis of Lexaria Bioscience Corp. stockBuy Signal & Fast Moving Stock Watchlists - Newser
Multi factor analysis applied to Lexaria Bioscience Corp.2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Can momentum traders help lift Lexaria Bioscience Corp.Portfolio Value Report & Low Drawdown Trading Strategies - Newser
Is Lexaria Bioscience Corp. Equity Warrant forming a bottoming baseInflation Watch & Fast Exit and Entry Strategy Plans - Newser
What institutional flow reveals about Lexaria Bioscience Corp. Equity WarrantGap Down & AI Driven Stock Reports - Newser
Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsEarnings Overview Summary & Consistent Return Strategy Ideas - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp.Sell Signal & Capital Efficiency Focused Ideas - Newser
Is Lexaria Bioscience Corp. stock overvalued or fairly pricedWeekly Profit Analysis & Verified Technical Signals - khodrobank.com
Multi asset correlation models including Lexaria Bioscience Corp.Trade Entry Report & Risk Adjusted Swing Trade Ideas - Newser
Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Key metrics from Lexaria Bioscience Corp. Equity Warrant’s quarterly dataQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
Will Lexaria Bioscience Corp. Equity Warrant benefit from macro trendsEarnings Risk Summary & Weekly High Conviction Trade Ideas - Newser
Detecting price anomalies in Lexaria Bioscience Corp. with AIWeekly Risk Summary & AI Enhanced Trading Signals - Newser
Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecastingEarnings Risk Summary & Weekly Setup with High ROI Potential - Newser
Is this a good reentry point in Lexaria Bioscience Corp. Equity Warrant2025 Macro Impact & Consistent Income Trade Ideas - Newser
Will Lexaria Bioscience Corp. Equity Warrant rebound enough to break even2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Sector ETF performance correlation with Lexaria Bioscience Corp. Equity WarrantPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
What analysts say about Lexaria Bioscience Corp. stockTrade Risk Summary & Weekly Top Performers Watchlists - khodrobank.com
Regression analysis insights on Lexaria Bioscience Corp. Equity Warrant performanceWeekly Market Report & Risk Controlled Daily Trade Plans - Newser
Will Lexaria Bioscience Corp. Equity Warrant benefit from geopolitical trends2025 Key Highlights & Free Daily Entry Point Trade Alerts - khodrobank.com
Comparing Lexaria Bioscience Corp. in custom built stock radarsWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
Is it too late to sell Lexaria Bioscience Corp.Weekly Investment Report & Community Verified Swing Trade Signals - Newser
What earnings revisions data tells us about Lexaria Bioscience Corp. Equity WarrantDip Buying & Long-Term Capital Growth Strategies - Newser
Applying chart zones and confluence areas to Lexaria Bioscience Corp. Equity WarrantBreakout Watch & Comprehensive Market Scan Reports - Newser
How hedge fund analytics apply to Lexaria Bioscience Corp. Equity Warrant stock2025 Key Highlights & Safe Entry Zone Tips - Newser
Can Lexaria Bioscience Corp. recover in the next quarterDip Buying & Short-Term Trading Alerts - Newser
Can Lexaria Bioscience Corp. disrupt its industry2025 Key Highlights & AI Powered Market Trend Analysis - khodrobank.com
Best data tools to analyze Lexaria Bioscience Corp. Equity Warrant stock2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
What data driven models say about Lexaria Bioscience Corp.’s futureMarket Activity Report & Free Technical Confirmation Trade Alerts - Newser
Take Profit: What are Lexaria Bioscience Corp.’s technical support levelsMarket Weekly Review & Scalable Portfolio Growth Methods - khodrobank.com
Is Lexaria Bioscience Corp. trending in predictive chart models2025 Bull vs Bear & Daily Volume Surge Signals - Newser
What is Lexaria Bioscience Corp. Equity Warrant s revenue forecastJuly 2025 Intraday Action & Weekly Setup with ROI Potential - khodrobank.com
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lexaria Bioscience Corp-Aktie (LEXX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER | Director |
Jul 30 '25 |
Buy |
0.91 |
11,900 |
10,866 |
281,912 |
| McKechnie William Edward | Director |
Jul 29 '25 |
Buy |
0.91 |
5,000 |
4,532 |
18,191 |
| DOCHERTY JOHN MARTIN | President & CSO |
Jul 29 '25 |
Buy |
0.93 |
5,376 |
4,989 |
5,376 |
| Carle Vanessa | Secretary |
Jul 29 '25 |
Buy |
0.91 |
750 |
682 |
750 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Jul 29 '25 |
Buy |
0.91 |
15,000 |
13,641 |
65,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 03 '24 |
Buy |
2.47 |
27,172 |
67,175 |
50,000 |
| CHRISTOPHER RICHARD | Chief Executive Officer |
Dec 02 '24 |
Buy |
2.24 |
22,828 |
51,217 |
22,828 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):